Michigan-based Priority Health plans a bold step in cancer detection and treatment: It will cover the cost of comprehensive genomic profiling for members diagnosed with aggressive forms of cancer, ...

Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...

Illumina, Inc. ILMN has secured the FDA’s approval for its in vitro diagnostic (IVD) TruSight Oncology (TSO) Comprehensive test and first two companion diagnostic (CDx) indications. The test analyses ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

Texas A&M University epidemiologist Rebecca Fischer says reopening our local economy isn't wrong necessarily--but it doesn't mean the threat of COVID-19 has passed. Fischer explained on First News at ...

The definition of comprehensive non-small cell lung cancer (NSCLC) testing is rapidly evolving with new biomarkers and therapies, according to Julia Rotow, MD, creating added challenges for community ...